Timoptic and Gallbladder disorder - a phase IV clinical study of FDA data

Summary:

Gallbladder disorder is reported as a side effect among people who take Timoptic (timolol maleate), especially for people who are female, 60+ old, also take Protonix, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Gallbladder disorder when taking Timoptic. It is created by eHealthMe based on reports of 4,201 people who have side effects when taking Timoptic from the FDA, and is updated regularly.

What is Timoptic?

Timoptic has active ingredients of timolol maleate. It is often used in glaucoma. eHealthMe is studying from 4,247 Timoptic users. Check the latest studies of Timoptic.

What is Gallbladder disorder?

Gallbladder disorder is found to be associated with 1,193 drugs and 1,786 conditions by eHealthMe. Check the latest studies of Gallbladder disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

4,201 people reported to have side effects when taking Timoptic.
Among them, 12 people (0.29%) have Gallbladder disorder.

Could Timoptic cause Gallbladder disorder?

Among these 12 people:

What is the gender of people who have Gallbladder disorder when taking Timoptic? *

female: 58.33 %
male: 41.67 %

What is the age of people who have Gallbladder disorder when taking Timoptic? *

What are other drugs people take besides Timoptic? *

What are other side effects people have besides Gallbladder disorder? *

Abdominal Pain: 7 people, 58.33%
Gallstones (stone formation by bile component): 6 people, 50.00%
Sepsis (a severe blood infection that can lead to organ failure and death): 6 people, 50.00%
Urinary Tract Infection: 5 people, 41.67%
Acute Kidney Failure: 5 people, 41.67%
Immunodeficiency Disorders: 4 people, 33.33%
Gastroduodenitis (an inflammation of the mucous membrane of the stomach and duodenum): 4 people, 33.33%
Ecchymosis (a discoloration of the skin resulting from bleeding underneath): 4 people, 33.33%
Ejection Fraction Abnormal (abnormality in percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat): 4 people, 33.33%
Enlarged Heart: 4 people, 33.33%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Timoptic and have Gallbladder disorder?

- Check whether Gallbladder disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Timoptic:

Timoptic (4,247 reports)

Browse all side effects of Timoptic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gallbladder disorder:

Gallbladder disorder (1,193 drugs)

Browse all the conditions that are associated with Gallbladder disorder:

Gallbladder disorder (1,786 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on timolol maleate (the active ingredients of Timoptic) and Timoptic (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.